VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
TAK-003
Preclinical
Biologic
Takeda
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Vaccine
1 trial
Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue
Completed
·
Takeda
·
Phase 3
·
NCT03423173
·
923 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for TAK-003. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
TAK-003 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for TAK-003. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Takeda company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Biologic
[2]
Highest Phase
Preclinical
[1]
Company
Takeda
Related News
